↓ Skip to main content

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

Overview of attention for article published in Psychopharmacology, November 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs
1 blog
policy
2 policy sources
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
110 Dimensions

Readers on

mendeley
156 Mendeley
Title
Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis
Published in
Psychopharmacology, November 2007
DOI 10.1007/s00213-007-0996-4
Pubmed ID
Authors

Kim Peterson, Marian S. McDonagh, Rongwei Fu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 3 2%
France 1 <1%
Brazil 1 <1%
Switzerland 1 <1%
Israel 1 <1%
Sweden 1 <1%
India 1 <1%
United States 1 <1%
Unknown 146 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 15%
Researcher 22 14%
Student > Master 22 14%
Student > Doctoral Student 17 11%
Student > Ph. D. Student 14 9%
Other 39 25%
Unknown 19 12%
Readers by discipline Count As %
Medicine and Dentistry 42 27%
Psychology 31 20%
Agricultural and Biological Sciences 12 8%
Neuroscience 9 6%
Social Sciences 7 4%
Other 29 19%
Unknown 26 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2023.
All research outputs
#1,898,988
of 23,924,386 outputs
Outputs from Psychopharmacology
#452
of 5,443 outputs
Outputs of similar age
#6,578
of 160,301 outputs
Outputs of similar age from Psychopharmacology
#1
of 27 outputs
Altmetric has tracked 23,924,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,443 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 160,301 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.